This statistic shows the top generic drugs producing pharmaceutical companies, by U.S. market share in 2013. In that year, Mylan Labs, Inc. had a market share of 13.4 percent on the unbranded generics market.
Top generic manufacturers
Generic drugs are medicinal products which are copying branded pharmaceutical drugs no longer protected by a patent. A generic drug has to be therapeutically equivalent to the original drug, what includes equivalent efficacy and safety. Generics are most often sold under their active ingredient’s name and the name of the manufacturing pharmaceutical company. The biggest advantage of a generic drug is its price, often significantly lower than that of the original branded product. Thus, generics make it possible to reduce expenditure on drugs.
Today, India is the world’s leading manufacturer of generic drugs. However, there was no Indian pharmaceutical company among the top generic drug-producing companies in the U.S. as of 2013. Israeli company Teva Pharmaceutical Industries Ltd., headquartered in Petah Tikva, is the world’s leading generic drug manufacturer. In 2013, the company generated more than 20 billion U.S. dollars of revenue worldwide. Approximately half of this amount was through generic drugs sales. Teva held some 12 percent of the U.S. generics market in 2013. Other prominent generic producers are Mylan Labs from the U.S., the Irish company Actavis, and Sandoz, a division of Swiss top global player Novartis.